pharmaceutical industry

What are the Challenges and Risks Associated with Nanotechnology in Pharmaceuticals?

Despite its advantages, nanotechnology in pharmaceuticals faces several challenges and risks:
1. Safety and Toxicity: The long-term effects of nanoparticles on human health and the environment are not fully understood, necessitating thorough safety evaluations.
2. Manufacturing and Scalability: Producing nanoparticles with consistent quality and properties on a large scale can be challenging.
3. Regulatory Issues: The regulatory framework for nanomedicines is still evolving, requiring clear guidelines for their approval and commercialization.
4. Cost: The development and production of nanomedicines can be expensive, potentially limiting their accessibility.

Frequently asked queries:

Partnered Content Networks

Relevant Topics